Bengaluru based startup Swish Club has rebranded itself as SwishX as the company pivots from its earlier IT asset management and device leasing business to an AI focused platform for pharmaceutical and medtech companies.
Under its new business model, SwishX is offering four AI driven solutions including Tender IQ, Contract IQ, Marketing IQ and Channel IQ. According to the company, these tools are aimed at automating processes such as identifying government tenders, managing hospital contracts, supporting doctor engagement and improving distributor and pharmacy sales operations.
The company said it is targeting $5 million in contracted ARR and over 100 enterprise clients by the end of FY27. SwishX also plans to expand into emerging markets including Latin America, Southeast Asia, the Middle East, Africa and Eastern Europe over the coming years.
Founded in 2023 by Dushyant Sapra, Suraj Kumar and Jai Anand, the startup previously operated as a platform enabling enterprises to rent laptops and lease smartphones. The company said it has now transitioned towards offering agentic AI solutions designed to help pharmaceutical companies streamline operations across sales, marketing, distribution and business growth functions.
SwishX said it has raised $2.2 million in seed funding from investors including Powerhouse Ventures, Blume Ventures, Sadev Ventures, Atrium Ventures and other backers. The company said these emerging markets represent a $400 billion pharma and medtech opportunity, with commercial operations expected to grow to $770 billion by 2033 at a CAGR of more than 12%.
SwishX currently claims to have achieved an ARR of $1 million and plans to raise a larger funding round going forward. The company also aims to build solutions covering the broader lifecycle of generic medicines, from development to commercial execution across multiple markets.
Dushyant Sapre, Founder and CEO, SwishX said, “India’s pharma sector, recognized as the Pharmacy of the World, drives revenues of over USD 65 billion and Emerging Markets combined drive USD 400 billion while distributing into over 200 countries. Manufacturing and R&D have become genuinely world-class, but how these companies sell, market, and distribute, is still stuck in the past.
He further added, “Companies often struggle to know where losses are happening, what is selling, which tenders matter most, or how effectively teams are executing in the market. AI Agents change that completely. The next big transformation in this industry is not going to happen in the lab. It is going to happen in how these companies go to market. For the first time, companies can move to real-time autonomous execution.”
